dexmedetomidine + bupivacaine (Tanta University)

dexmedetomidine + bupivacaine is a combination analgesic therapy consisting of the alpha-2 adrenergic agonist dexmedetomidine and the local anesthetic bupivacaine. Developed by researchers at Tanta University, this combination is primarily investigated for managing postoperative pain following arthroscopic knee surgery. Bupivacaine provides regional anesthesia by binding to and inhibiting voltage-gated sodium channels, thereby preventing the propagation of action potentials in nerve fibers. Dexmedetomidine serves as a synergistic adjuvant that enhances the quality and duration of the local anesthetic block through its action on alpha-2 adrenergic receptors, which modulates pain signaling in the spinal cord and peripheral nerves. The combination is typically administered via intra-articular injection at the conclusion of surgical procedures.

Other names

Dexmedetomidine Bupivacaineintra-articular bupivacaine dexmedetomidine